Mitochondrial Metabolism, Redox State and Immunology in Cancer

A special issue of Metabolites (ISSN 2218-1989). This special issue belongs to the section "Endocrinology and Clinical Metabolic Research".

Deadline for manuscript submissions: 31 December 2025 | Viewed by 203

Special Issue Editors


E-Mail Website
Guest Editor
Department of Physiology, National Institute of Cardiology Ignacio Chavez, Mexico City 04510, Mexico
Interests: cancer; mitochondria metabolism; redox state

E-Mail Website
Guest Editor
Immunology Department, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico
Interests: cancer; mitochondria metabolism; redox state

Special Issue Information

Dear Colleagues,

Several antitumor therapies exert their function through immunity and/or redox status management. Both of these therapeutic targets are closely related to mitochondrial metabolism in the tumoral microenvironment, and involve immune cells, stromal cells, blood vessels, and the extracellular matrix. For example, some types of cancer have been found to require certain levels of reactive oxygen species (ROS) for their maintenance and growth, while other types of cancer, instead, need reduced levels of ROS, with mitochondria being the main organelles in the regulation of ROS. In addition, immune cells also depend on mitochondrial ROS and their metabolism to be activated or inhibited during cancer elimination. In support of this, it has been observed that cytotoxic T cells need mitochondrial ROS to activate and induce their cytotoxic activity against tumors, but on the other hand, elevated levels of ROS can activate regulatory T cells which suppress the antitumoral effects of cytotoxic T cells, promoting tumor growth. On the other hand, it should be noted that elevated levels of ROS also induce tumor death, as ROS can overcome the threshold of resistance to oxidative stress (OS), inducing mitochondrial damage and dysfunction and, consequently, the cell death of tumor cells. Finding these windows of opportunity in cancer elimination is a challenge. Therefore, the redox state and mitochondrial metabolism in both cancer cells and the immune system associated with tumor cell eradication are key events for cancer elimination. This Special Issue welcomes reviews and original research manuscripts exploring the effects of ROS and mitochondrial metabolism on both tumor cells and immune cells associated with their elimination, including treatments targeting these two fundamental aspects of cancer progression.

Dr. Alfredo Cruz-Gregorio
Prof. Dr. Gladis Fragoso
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Metabolites is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • immune system
  • mitochondria
  • redox state
  • cancer

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop